Cochrane · systematic review · CD002009

Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis

Bhatt, J, Jahnke, N, Smyth, AR · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library

Cystic Fibrosis and Genetic Disorders2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
6
No studies
1
Included studies
NR
No studies 1 · 14.3%Ungraded 0 · 0%Very low 0 · 0%Low 3 · 42.9%Moderate 3 · 42.9%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Current version only

Comparison

Population: adults and children with cystic fibrosis
CD002009.PUB7 (current) · 7 questions
OutcomeEffectEvidenceStatus / GRADE
Lung function Mean percentage change in FEV1
no estimate extracted3 studies · 289 participantsModerate
Downgraded: risk of bias, imprecision, indirectness
Lung function Mean percentage change in FVC (% predicted)
no estimate extracted2 studies · 70 participantsLow
Downgraded: risk of bias, imprecision, indirectness
Nutritional status BMI
no estimate extracted1 study · 41 participantsLow
Downgraded: risk of bias, imprecision, indirectness
Time to first exacerbation requiring intravenous antibiotics
no estimate extracted1 study · 113 participantsModerate
Downgraded: risk of bias, imprecision, indirectness
Antibiotic resistance patterns following treatment
no estimate extractedNRNo studies
Ototoxicity An increase in auditory threshold of 20 dB or more over any frequency range
RR 0.56 [0.04, 7.96]3 studies · 266 participantsLow
Downgraded: risk of bias, imprecision, indirectness
Nephrotoxicity The percentage change in creatinine over baseline
no estimate extracted3 studies · 245 participantsModerate
Downgraded: risk of bias, imprecision, indirectness

Comparison

Population: adults and children with cystic fibrosis
CD002009.PUB6 · 7 questions
OutcomeEffectEvidenceStatus / GRADE
Lung function Mean percentage change in FEV₁
no estimate extracted3 studies · 289 participantsModerate
Downgraded: risk of bias, imprecision, indirectness
Lung function Mean percentage change in FVC (% predicted)
no estimate extracted2 studies · 70 participantsLow
Downgraded: risk of bias, imprecision, indirectness
Nutritional status BMI
no estimate extracted1 study · 41 participantsLow
Downgraded: risk of bias, imprecision, indirectness
Time to first exacerbation requiring intravenous antibiotics
no estimate extracted1 study · 113 participantsModerate
Downgraded: risk of bias, imprecision, indirectness
Antibiotic resistance patterns following treatment
no estimate extractedNRNo studies
Ototoxicity An increase in auditory threshold of 20 dB or more over any frequency range
RR 0.56 [0.04, 7.96]3 studies · 266 participantsLow
Downgraded: risk of bias, imprecision, indirectness
Nephrotoxicity The percentage change in creatinine over baseline
no estimate extracted3 studies · 245 participantsModerate
Downgraded: risk of bias, imprecision, indirectness